Antibiotics in acute bronchitis: A meta-analysis

American Journal of Medicine

Volumn 107, Issue 1, 1999, Pages 62-67

  Bent, Stephen ^a,b   Saint, Sanjay ^a,b   Vittinghoff, Eric ^a   Grady, Deborah ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN;

ADENOVIRUS; ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SPUTUM; TREATMENT OUTCOME;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BRONCHITIS; DOXYCYCLINE; ERYTHROMYCIN; HUMANS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0033166478     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00167-9     Document Type: Article

References (49)

1. Saint S., Bent S., Vittinghoff E., Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations a meta-analysis . JAMA. 273:1995;957-960.
2. Woodwell D.A., Schappert S.M. National Ambulatory Medical Care Survey 1993 summary . Advance Data. 270:1995;1-20.
3. Billas A. Lower respiratory tract infections. Prim Care. 17:1990;811-824.
4. Chow A.W., Hall C.B., Klein J.O., Kammer R.B., Meyer R.D., Remington J.S. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 15:1992;S62-S88.
5. Hitt J.A., Gerding D.N. Sputum antimicrobial levels and clinical outcome in bronchitis. Semin Respir Infect. 6:1991;122-128.
6. Hosker H.S., Jones G.M., Hawkey P. Management of community acquired lower respiratory tract infection. BMJ. 308:1994;701-705.
7. Gleckman R.A. Bronchial infections acute bronchitis and acute exacerbation of chronic bronchitis . Compr Ther. 13:1987;44-48.
8. Boldy D.A., Skidmore S.J., Ayres J.G. Acute bronchitis in the community clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine . Respir Med. 84:1990;377-385.
9. Rodnick J.E., Gude J.K. The use of antibiotics in acute bronchitis and acute exacerbations of chronic bronchitis. West J Med. 149:1988;347-351.
10. Trigg C.J., Davies R.J. Antibiotic prescribing for bronchitis time for a change? Respir Med. 88:1994;161-163.
11. Garibaldi R.A. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med. 78:1985;32-37.
12. Dunlay J., Reinhardt R. Clinical features and treatment of acute bronchitis. J Fam Pract. 18:1984;719-722.
13. Vogel F. A guide to the treatment of lower respiratory tract infections. Drugs. 50:1995;62-72.
14. Hueston W.J., Mainous A.G. III. Acute bronchitis. American Family Physician. 57:1998;1270-1276.
15. Falck G., Heyman L., Gnarpe J., Gnarpe H. Chlamydia pneumoniae (TWAR) a common agent in acute bronchitis . Scand J Infect Dis. 26:1994;179-187.
16. Grayston J.T., Aldous M.B., Easton A., et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis. 168:1993;1231-1235.
17. Ridgway G. TWAR and changing respiratory infections. Practitioner. 234:1990;790-792.
18. Macfarlane J.T., Colville A., Guion A., Macfarlane R.M., Rose D.H. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet. 341:1993;511-514.
19. Macfarlane J., Prewett J., Guion A., Gard P. Community acquired lower respiratory tract infection. Bacterial infection not uncommon. BMJ. 308:1994;1239.
20. Dere W.H. Acute bronchitis results of U.S. and European trials of antibiotic therapy . Am J Med. 92:1992;53S-57S.
21. Staley H., McDade H.B., Paes D. Is an objective assessment of antibiotic therapy in exacerbations of chronic bronchitis possible? J Antimicrob Chemother. 31:1993;193-197.
22. Lode H., Schaberg T., Raffenberg M., Mauch H. Diagnostic problems in lower respiratory tract infections. J Antimicrob Chemother. 32:1993;29-37.
23. He Q., Viljanen M.K., Arvilommi H., Aittanen B., Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA. 280:1998;635-637.
24. Mainous A.G. III, Zoorob R.J., Hueston W.J. Current management of acute bronchitis in ambulatory care the use of antibiotics and bronchodilators . Arch Fam Med. 5:1996;79-83.
25. Gonzales R., Steiner J.F., Sande M.A. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 278:1997;901-904.
26. Nyquist A., Gonzales R., Steiner J.F., Sande M.A. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 279:1998;875-877.
27. McCaig L.F., Hughes J.M. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 273:1995;214-219.
28. Brickfield F.X., Carter W.H., Johnson R.E. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract. 23:1986;119-122.
29. Dunlay J., Reinhardt R., Roi L.D. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract. 25:1987;137-141.
30. Franks P., Gleiner J.A. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract. 19:1984;185-190.
31. Howie J.G., Clark G.A. Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice. Lancet. 2:1970;1099-1102.
32. Scherl E.R., Riegler S.L., Cooper J.K. Doxycycline in acute bronchitis a randomized double-blind trial . J Ky Med Assoc. 85:1987;539-541.
33. Stott N.C., West R.R. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. BMJ. 2:1976;556-559.
34. Williamson H. Jr. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract. 19:1984;481-486.
35. Verheij T.J., Hermans J., Mulder J.D. Effects of doxycycline in patients with acute cough and purulent sputum a double blind placebo controlled trial . Br J Gen Pract. 44:1994;400-404.
36. Hueston W.J. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract. 39:1994;437-440.
37. King D.E., Williams W.C., Bishop L. Effectiveness of erythromycin in the treatment of acute bronchitis. J Fam Pract. 42:1996;601-605.
38. Perlman P.E., Ginn D.R. Respiratory infections in ambulatory adults. Choosing the best treatment. Postgrad Med. 87:1990;175-184.
39. Orr P.H., Scherer K., Macdonald A., Moffatt M.E. Randomized placebo-controlled trials of antibiotics for acute bronchitis a critical review of the literature . J Fam Pract. 36:1993;507-512.
40. Hennekens C.H., Buring J.E., Hebert P.R. Implications of overviews of randomized trials. Stat Med. 6:1987;397-409.
41. Light R.J., Pillemer D.B. Summing Up The Science of Reviewing Research . 1984;Harvard University Press, Cambridge, MA.
42. Yusuf S. Obtaining medically meaningful answers from an overview of randomized clinical trials. Stat Med. 6:1987;281-294.
43. Sacks H.S., Berrier J., Reitman D., Ancona-Berk V.A., Chalmers T.C. Meta-analyses of randomized controlled trials. NEJM. 316:1987;450-455.
44. Petitti D.B. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis Methods for Quantitative Synthesis in Medicine . 1994;Oxford University Press, New York.
45. Kristinsson K.G. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist. 3:1997;117-123.
46. Seppala H., Klaukka T., Vuopio-Varkila J. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. NEJM. 337:1997;441-446.
47. Molstad S., Arvidsson E., Eliasson I. Production of beta-lactamase in respiratory tract bacteria in children relationship to antibiotic use . Scand J Prim Health Care. 10:1992;16-20.
48. Mainous A.G. III, Zoorob R.J., Oler M.J., Haynes D.M. Patient knowledge of upper respiratory infections implications for antibiotic expectations and unnecessary utilization . J Fam Pract. 45:1997;75-83.
49. Gonzales R., Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis? Lancet. 345:1995;665-666.